intranasal glutathione in parkinson& 39 Parkinson's Disease Treatment Parkinson's Disease - 2025 -
Description
Similarly, drugs like atorvastatin have been repurposed to delay ARHL progression by activating pathways such as HSF1/Sirt1, which bolster antioxidant defenses and maintain mitochondrial structure (Choo et al., 2022)
Larger and longer studies are needed before drawing firm conclusions
To determine oxidative stress on the cells dosed with menadione, we monitored GSSG levels (Figure 3, Panel B, and Figure 4, Panel B)
Using a pipette, transfer 50 l of serum to a 1.5 ml EP tube
